Published in Ann Neurol on January 01, 2006
Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience (2008) 1.76
Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain (2007) 1.54
Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci (2008) 1.18
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Relat Disord (2008) 1.16
Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord (2008) 1.16
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience (2009) 1.14
Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain (2009) 1.11
Functional imaging in Huntington's disease. Exp Neurol (2009) 1.08
Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry (2012) 1.06
Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol (2007) 1.03
Brain networks in Huntington disease. J Clin Invest (2011) 1.02
Functional connectivity of the prefrontal cortex in Huntington's disease. J Neurol Neurosurg Psychiatry (2006) 0.95
Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats. Exp Neurol (2010) 0.93
Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. J Cereb Blood Flow Metab (2011) 0.92
Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies. Front Psychiatry (2014) 0.92
Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J Neurol Neurosurg Psychiatry (2009) 0.90
Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation. J Neurosci (2012) 0.89
Emotion recognition and experience in Huntington disease: a voxel-based morphometry study. J Psychiatry Neurosci (2011) 0.89
Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease. Mov Disord (2009) 0.87
Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. Neuroimage (2013) 0.85
"Pre-symptomatic" Huntington's disease. Handb Clin Neurol (2008) 0.85
Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease. Mov Disord (2010) 0.85
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins. Eur J Nucl Med Mol Imaging (2009) 0.83
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Front Cell Neurosci (2014) 0.81
The assessment of neurological systems with functional imaging. Brain Lang (2006) 0.81
Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS One (2009) 0.81
Movement sequencing in Huntington disease. World J Biol Psychiatry (2014) 0.80
Neural correlates of impaired emotion processing in manifest Huntington's disease. Soc Cogn Affect Neurosci (2013) 0.80
Early Detection of Huntington Disease. Future Neurol (2010) 0.79
Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation. PLoS One (2015) 0.76
The importance of considering all attributes of memory in behavioral endophenotyping of mouse models of genetic disease. Behav Neurosci (2012) 0.76
Monitoring Huntington's disease progression through preclinical and early stages. Neurodegener Dis Manag (2012) 0.75
Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis. EJNMMI Res (2017) 0.75
Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease. Sci Rep (2017) 0.75
Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study. Brain Behav (2016) 0.75
Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease. PLoS One (2016) 0.75
PET Imaging in Huntington's Disease. J Huntingtons Dis (2015) 0.75
Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling. Front Hum Neurosci (2015) 0.75
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology (2002) 5.40
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet (2004) 4.73
The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex (2000) 3.24
Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med (1999) 2.30
fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol (2004) 2.10
Patterns of regional brain activation associated with different forms of motor learning. Brain Res (2000) 2.10
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain (1998) 1.84
Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. J Neurol (2004) 1.64
Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol (2003) 1.63
The differential effect of PD and normal aging on early explicit sequence learning. Neurology (2003) 1.52
Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol (2002) 1.51
Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum Brain Mapp (2001) 1.48
Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2(15)O regional cerebral blood flow three-dimensional imaging technique. J Cereb Blood Flow Metab (1993) 1.41
Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol (1995) 1.39
Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry (2004) 1.35
Profile of cognitive progression in early Huntington's disease. Neurology (2003) 1.35
Functional brain changes in presymptomatic Huntington's disease. Ann Neurol (2004) 1.34
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med (2001) 1.25
Anatomical investigation of projections from thalamus to posterior parietal cortex in the rhesus monkey: a WGA-HRP and fluorescent tracer study. J Comp Neurol (1990) 1.24
Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp (2003) 1.23
Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage (2004) 1.21
The metabolic topography of posthypoxic myoclonus. Neurology (2004) 1.16
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain (2003) 1.13
Effects of levodopa on motor sequence learning in Parkinson's disease. Neurology (2003) 1.07
Afferent connections of the caudolateral orbitofrontal cortex taste area of the primate. Neuroscience (1995) 1.04
Recent advances in Huntington's disease: implications for experimental therapeutics. Curr Opin Neurol (2002) 1.02
Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia (2000) 0.99
Huntington's disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med (1994) 0.99
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport (2004) 0.96
Pallidal stimulation for parkinsonism: improved brain activation during sequence learning. Ann Neurol (2002) 0.92
Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Res (1999) 0.90
Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord (1996) 0.86
Distinct neural systems underlie learning visuomotor and spatial representations of motor skills. Hum Brain Mapp (2005) 0.85
Dissociation between intentional and incidental sequence learning in Huntington's disease. Brain (2001) 0.84
Functional changes in brain activity during acquisition and practice of movement sequences. Motor Control (2004) 0.82
Huntington's disease. Psychiatr Clin North Am (1997) 0.80
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (2007) 7.01
Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol (2006) 3.57
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry (2007) 2.71
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab (2006) 2.42
Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry (2002) 2.41
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain (2007) 2.17
Neurocognitive signs in prodromal Huntington disease. Neuropsychology (2011) 2.14
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet (2011) 2.05
The value of positron emission tomography in the clinical evaluation of dementia. J Am Geriatr Soc (2003) 2.05
Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ (2009) 2.02
Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci (2009) 2.01
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.98
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol (2006) 1.94
Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage (2006) 1.92
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet (2003) 1.85
Coercion and informed consent in research involving prisoners. Compr Psychiatry (2003) 1.84
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage (2006) 1.84
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index. Arch Clin Neuropsychol (2006) 1.77
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci (2010) 1.76
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord (2009) 1.73
Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study. J Neurophysiol (2003) 1.71
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers. Mov Disord (2011) 1.68
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain (2007) 1.66
Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment. Int Psychogeriatr (2008) 1.64
Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol (2003) 1.63
Measures of growth in children at risk for Huntington disease. Neurology (2012) 1.59
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci (2008) 1.56
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol (2010) 1.56
Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia (2007) 1.54
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. Mov Disord (2012) 1.54
Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry (2010) 1.53
The differential effect of PD and normal aging on early explicit sequence learning. Neurology (2003) 1.52
Fully automated analysis using BRAINS: AutoWorkup. Neuroimage (2010) 1.52
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci (2010) 1.50
Predictors of diagnosis in Huntington disease. Neurology (2007) 1.48
Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol (2007) 1.47
The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biol Psychiatry (2003) 1.46
Earliest functional declines in Huntington disease. Psychiatry Res (2010) 1.45
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain (2009) 1.44
Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.44
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage (2010) 1.43
Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases. J Neurosurg (2011) 1.43
Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol (2007) 1.42
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41
Abnormal metabolic networks in atypical parkinsonism. Mov Disord (2008) 1.39
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol (2002) 1.39
Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc (2007) 1.38
Microstructural white matter changes in primary torsion dystonia. Mov Disord (2008) 1.38
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage (2010) 1.36
Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage (2009) 1.36
Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol (2002) 1.35
fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc (2007) 1.35
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain (2010) 1.35
Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain (2010) 1.35
White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol (2005) 1.34
Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol Dis (2010) 1.34
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A (2011) 1.33
Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain (2007) 1.33
Morphology of the cerebral cortex in preclinical Huntington's disease. Am J Psychiatry (2007) 1.32
Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol (2012) 1.32
Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. Clin Positron Imaging (1998) 1.31
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med (2002) 1.31
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet (2006) 1.30
Patient and caregiver quality of life in Huntington's disease. Mov Disord (2008) 1.29
Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.29
Imaging essential tremor. Mov Disord (2010) 1.27
Factor analysis of the frontal systems behavior scale (FrSBe). Assessment (2003) 1.27
Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp (2004) 1.26
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab (2006) 1.26
Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol (2004) 1.24
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain (2008) 1.24
Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging (2006) 1.24